Sorrento TherapeuticsSRNE
13F holders, Q4 2025 (December 31)5holders +1
2new positions
1sold out
$0.00avg. 13F price*
At the end of Q4 2025, 5 institutions reported holding Sorrento Therapeutics Inc. (SRNE) in their 13F filings, up 1 from Q3 2025. 2 opened new positions and 1 sold out. The largest holders were Kingswood Wealth Advisors, LLC ($67), Huntington National Bank ($14) and Oakworth Capital, Inc. ($1).
- Company
- Sorrento Therapeutics Inc.
- CUSIP
- 83587F202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $67 |
| Exits | 1 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 25,655 shares bought and 70 shares sold, net +25,585 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Kingswood Wealth Advisors, LLC | 0.00% | New | 25,650 | $67 |
| Huntington National Bank | 0.00% | No change | 5,001 | $14 |
| Oakworth Capital, Inc. | 0.00% | No change | 350 | $1 |
| Ancora Advisors LLC | 0.00% | New | 5 | $0 |
| Financial Gravity Asset Management, Inc. | 0.00% | No change | 18 | $0 |
"% of holder's portfolio" is SRNE's weight in each manager's 13F, not the share of Sorrento Therapeutics Inc. the manager owns.